Elevance Health Ownership
| ELV Stock | USD 403.60 6.12 1.54% |
Shares in Circulation | First Issued 2001-09-30 | Previous Quarter 233.4 M | Current Value 233.1 M | Avarage Shares Outstanding 346.3 M | Quarterly Volatility 136.4 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Elevance |
Elevance Stock Ownership Analysis
About 92.0% of the company shares are held by institutions such as insurance companies. The book value of Elevance Health was currently reported as 188.74. The company has Price/Earnings To Growth (PEG) ratio of 0.74. Elevance Health recorded earning per share (EPS) of 27.47. The entity last dividend was issued on the 5th of December 2024. The firm had 2:1 split on the 1st of June 2005. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana. Elevance Health operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 98200 people. To learn more about Elevance Health call Gail Boudreaux at 833 401 1577 or check out https://www.elevancehealth.com.Besides selling stocks to institutional investors, Elevance Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Elevance Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Elevance Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Elevance Health Quarterly Liabilities And Stockholders Equity |
|
Elevance Health Insider Trades History
Less than 1% of Elevance Health are currently held by insiders. Unlike Elevance Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Elevance Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Elevance Health's insider trades
Elevance Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Elevance Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Elevance Health backward and forwards among themselves. Elevance Health's institutional investor refers to the entity that pools money to purchase Elevance Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Norges Bank | 2024-06-30 | 3 M | Nuveen Asset Management, Llc | 2024-06-30 | 2.9 M | Baillie Gifford & Co Limited. | 2024-09-30 | 2.8 M | Alliancebernstein L.p. | 2024-06-30 | 2.8 M | Massachusetts Financial Services Company | 2024-09-30 | 2.4 M | Jpmorgan Chase & Co | 2024-06-30 | 2.4 M | Artisan Partners Limited Partnership | 2024-06-30 | 2.4 M | Legal & General Group Plc | 2024-06-30 | 2.2 M | Arnhold & S. Bleichroeder Advisers, Llc | 2024-09-30 | 2.2 M | Vanguard Group Inc | 2024-09-30 | 21.3 M | Blackrock Inc | 2024-06-30 | 20.7 M |
Elevance Health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Elevance Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Elevance Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Elevance Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ronald Penczek over a week ago Disposition of 1055 shares by Ronald Penczek of Elevance Health at 475.17 subject to Rule 16b-3 | ||
Blair Todt over a week ago Disposition of 7 shares by Blair Todt of Elevance Health at 480.49 subject to Rule 16b-3 | ||
Peru Ramiro G over three months ago Disposition of 753 shares by Peru Ramiro G of Elevance Health at 531.52 subject to Rule 16b-3 | ||
Neri Antonio F over six months ago Acquisition by Neri Antonio F of 388 shares of Elevance Health subject to Rule 16b-3 | ||
Ronald Penczek over six months ago Disposition of tradable shares by Ronald Penczek of Elevance Health at 454.35 subject to Rule 16b-3 | ||
Schneider Ryan M. over six months ago Acquisition by Schneider Ryan M. of 457 shares of Elevance Health subject to Rule 16b-3 | ||
Charles Kendrick over six months ago Acquisition by Charles Kendrick of 7786 shares of Elevance Health at 469.03 subject to Rule 16b-3 | ||
Zielinski Thomas C over a year ago Sale by Zielinski Thomas C of 5254 shares of Elevance Health |
Elevance Health's latest congressional trading
Congressional trading in companies like Elevance Health, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Elevance Health by those in governmental positions are based on the same information available to the general public.
| 2024-09-25 | Representative William R Keating | Acquired Under $15K | Verify | ||
| 2024-09-06 | Representative John James | Acquired Under $15K | Verify | ||
| 2024-09-02 | Representative John James | Acquired Under $15K | Verify | ||
| 2024-08-21 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2024-08-06 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2023-11-01 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
| 2023-10-31 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
| 2023-10-12 | Senator Markwayne Mullin | Acquired $15K to $50K | Verify |
Elevance Health Outstanding Bonds
Elevance Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Elevance Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Elevance bonds can be classified according to their maturity, which is the date when Elevance Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| US03674XAS53 Corp BondUS03674XAS53 | View | |
| US03674XAQ97 Corp BondUS03674XAQ97 | View | |
| ANTHEM INC Corp BondUS036752AN31 | View | |
| ANTHEM INC Corp BondUS036752AM57 | View | |
| ANTHEM INC Corp BondUS036752AL74 | View | |
| ELV 41 15 MAY 32 Corp BondUS036752AT01 | View | |
| ANTHEM INC Corp BondUS036752AS28 | View |
Elevance Health Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 5th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 31st of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 23rd of October 2024 Other Reports | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Elevance Stock Analysis
When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.